Nicholas Curtis - LENSAR CEO President

LNSR Stock  USD 7.69  0.25  3.36%   

CEO

Nicholas Curtis is CEO President of LENSAR Inc
Age 68
Address 2800 Discovery Drive, Orlando, FL, United States, 32826
Phone888 536 7271
Webhttps://www.lensar.com

Nicholas Curtis Latest Insider Activity

Tracking and analyzing the buying and selling activities of Nicholas Curtis against LENSAR stock is an integral part of due diligence when investing in LENSAR. Nicholas Curtis insider activity provides valuable insight into whether LENSAR is net buyers or sellers over its current business cycle. Note, LENSAR insiders must abide by specific rules, including filing SEC forms every time they buy or sell LENSAR'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

LENSAR Management Efficiency

The company has return on total asset (ROA) of (0.0938) % which means that it has lost $0.0938 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3838) %, meaning that it created substantial loss on money invested by shareholders. LENSAR's management efficiency ratios could be used to measure how well LENSAR manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/28/2024, Return On Tangible Assets is likely to drop to -0.26. In addition to that, Return On Capital Employed is likely to drop to -0.22. At this time, LENSAR's Net Tangible Assets are relatively stable compared to the past year. As of 11/28/2024, Non Currrent Assets Other is likely to grow to about 2.2 M, while Total Current Assets are likely to drop slightly above 38.9 M.
LENSAR Inc currently holds 2.31 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. LENSAR Inc has a current ratio of 3.08, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about LENSAR's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 6 records

CEO Age

Walter RosebroughSTERIS plc
70
Roland DiggelmannSmith Nephew SNATS
53
Robert FordAbbott Laboratories
50
Deepak NathSmith Nephew SNATS
52
Kevin SayerDexCom Inc
66
Vafa JamaliZimVie Inc
54
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida. LENSAR operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 110 people. LENSAR Inc (LNSR) is traded on NASDAQ Exchange in USA. It is located in 2800 Discovery Drive, Orlando, FL, United States, 32826 and employs 130 people. LENSAR is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

LENSAR Inc Leadership Team

Elected by the shareholders, the LENSAR's board of directors comprises two types of representatives: LENSAR inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LENSAR. The board's role is to monitor LENSAR's management team and ensure that shareholders' interests are well served. LENSAR's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LENSAR's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA II, CFO Secretary
Nicholas Curtis, CEO President
Alan Connaughton, Chief Officer
Kendra Wong, Principal Officer

LENSAR Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LENSAR a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with LENSAR

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LENSAR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENSAR will appreciate offsetting losses from the drop in the long position's value.

Moving together with LENSAR Stock

  0.73GH Guardant HealthPairCorr
  0.76LH LaboratoryPairCorr

Moving against LENSAR Stock

  0.92EKSO Ekso Bionics HoldingsPairCorr
  0.75VERO Venus ConceptPairCorr
  0.58CI Cigna CorpPairCorr
  0.45DRIO DarioHealth CorpPairCorr
The ability to find closely correlated positions to LENSAR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LENSAR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LENSAR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LENSAR Inc to buy it.
The correlation of LENSAR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LENSAR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LENSAR Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LENSAR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for LENSAR Stock Analysis

When running LENSAR's price analysis, check to measure LENSAR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENSAR is operating at the current time. Most of LENSAR's value examination focuses on studying past and present price action to predict the probability of LENSAR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENSAR's price. Additionally, you may evaluate how the addition of LENSAR to your portfolios can decrease your overall portfolio volatility.